Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Tacrine-Based Hybrids: Expanding Multi-Target Approaches in
2026-06-03
The reference review systematically details how tacrine-based hybrids have evolved in Alzheimer’s disease research, tracing the shift from single-target cholinesterase inhibition to multi-targeted molecular designs. This work highlights the mechanistic logic, synthesis strategies, and translational challenges of tacrine derivatives, offering a scaffold-centric roadmap for future neurodegenerative disease modeling.
-
WM-8014 as a KAT6A Inhibitor: Applied Workflows and Assay Pr
2026-06-03
WM-8014 redefines selective histone acetyltransferase inhibition in cancer biology and epigenetic discovery, enabling robust control of oncogene-induced senescence without cytotoxicity. This guide translates cutting-edge findings into actionable protocols, advanced assay strategies, and troubleshooting know-how for reliable, reproducible results.
-
Angiotensin 1/2 (2-7): Precision Tools for RAS Innovation
2026-06-02
This article delivers a thought-leadership perspective on Angiotensin 1/2 (2-7), blending molecular insight, evidence-driven translational guidance, and strategic workflow recommendations. We contextualize the peptide’s mechanistic role in the renin-angiotensin system (RAS), spotlight its expanding relevance in blood pressure regulation and infectious disease research, and articulate how APExBIO’s offering enables next-generation studies with unmatched purity and reproducibility. Drawing from the latest literature and advanced protocols, we delineate how this vasoconstrictor peptide fragment bridges cardiovascular and viral pathogenesis domains, while candidly assessing limitations and future outlook.
-
Pharmacokinetic Variability of CSBTA in MASH: Insights for D
2026-06-02
This study presents a detailed pharmacokinetic and tissue distribution analysis of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH), revealing how disease state and dosing frequency influence systemic exposure and hepatic accumulation. The findings highlight the importance of transporter and enzyme modulation in optimizing CSBTA-based interventions for MASLD/MASH.
-
Technical Use of Angiotensin I/II (1-5) in RAS Modeling
2026-06-01
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled modeling of the renin-angiotensin system in cardiovascular and renal workflows. It is suited for research on blood pressure regulation and aldosterone signaling, but should not be used outside these domains or in exploratory peptide signaling studies.
-
Applied Workflows with Acetylspiramycin (Spiramycin B) in An
2026-06-01
Harness the dual antimicrobial and immunomodulatory properties of Acetylspiramycin (Spiramycin B) for cutting-edge resistance studies and host-pathogen investigations. This guide details robust experimental workflows, troubleshooting strategies, and cross-domain insights grounded in recent clinical and laboratory research.
-
Sodium Ascorbate: Advanced Protocols for Glioblastoma Resear
2026-05-31
Sodium Ascorbate, a mineral salt of ascorbic acid, sets itself apart with its unique solubility profile and proven ability to induce intracellular ROS, making it a powerhouse for translational glioblastoma research. This guide delivers stepwise protocols, troubleshooting, and experimental strategies that harness its mechanistic advantages for reliable cancer cell assays.
-
Fosinopril Sodium: Optimized ACE Inhibitor Workflows in Hype
2026-05-30
Fosinopril sodium distinguishes itself in hypertension and cardiovascular disease research through robust dual elimination pathways and a unique phosphinic acid ACE inhibition mechanism. This article provides actionable protocol enhancements, advanced applications, and troubleshooting guidance, empowering researchers to maximize reproducibility using APExBIO’s high-purity compound.
-
Acridine Orange hydrochloride: Technical Guide for Nucleic A
2026-05-29
Acridine Orange hydrochloride is a dual-fluorescent dye enabling precise differentiation of DNA and RNA in situ, supporting workflows like cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is not recommended for long-term storage of prepared solutions or for applications outside nucleic acid staining. This article summarizes practical use, protocol parameters, and troubleshooting strategies for research labs.
-
KX2-391 Dihydrochloride: Systems Biology of Dual Inhibition
2026-05-29
Explore KX2-391 dihydrochloride's dual mechanism as both a Src kinase and tubulin polymerization inhibitor. This article uniquely analyzes its systems-level impact on signaling networks, guided by recent scientific discoveries and practical assay insights.
-
Applied Workflows with Angiotensin 1/2 (2-7) Peptide
2026-05-28
Angiotensin 1/2 (2-7) peptide opens new frontiers for modeling blood pressure regulation and viral receptor interactions. This article distills advanced protocols, troubleshooting tactics, and cross-domain insights for maximizing research reproducibility and impact.
-
WM-8014: Precision KAT6A Inhibitor for Epigenetic Assays
2026-05-28
WM-8014 offers unmatched selectivity and reversible inhibition of KAT6A/B, enabling researchers to dissect oncogene-induced senescence and cell cycle arrest with minimal cytotoxicity. This article provides hands-on guidance for deploying WM-8014 in advanced epigenetic and cancer biology workflows, with troubleshooting tips to maximize experimental success.
-
HotStart Universal 2X Green qPCR Master Mix: Workflow Advanc
2026-05-27
Leveraging the HotStart Universal 2X Green qPCR Master Mix unlocks precise, high-efficiency gene expression analysis for complex models such as diabetic wound healing. Its antibody-mediated hot-start and universal ROX compatibility streamline setup, reduce troubleshooting, and ensure data reliability—making it indispensable for advanced biomedical research.
-
Acetoacetic Acid Sodium Salt in Energy Metabolism Research
2026-05-27
Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is transforming energy metabolism and diabetes research with its high purity, robust solubility, and validated role as a ketone body metabolite. This article breaks down practical protocols, advanced applications, and troubleshooting strategies that maximize reproducibility and translational impact, leveraging APExBIO’s rigorously benchmarked reagent.
-
Precision Cell Assays: Otilonium Bromide for Reliable Result
2026-05-26
This scenario-driven guide equips biomedical researchers with validated strategies for cell-based assays using Otilonium Bromide (SKU B1607). By analyzing real-world workflow challenges, it demonstrates how this antimuscarinic agent from APExBIO enhances reproducibility, solubility, and confidence in cholinergic signaling research.